The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Phillips, J. M.
Right arrow Articles by Cooke, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phillips, J. M.
Right arrow Articles by Cooke, A.
The Journal of Immunology, 2001, 167: 6087-6091.
Copyright © 2001 by The American Association of Immunologists

Cutting Edge

Cutting Edge: Interactions Through the IL-10 Receptor Regulate Autoimmune Diabetes1

Jenny M. Phillips, Nicole M. Parish, Martin Drage and Anne Cooke2

Department of Pathology, University of Cambridge, Cambridge, United Kingdom

BDC2.5/nonobese diabetic (NOD) transgenic mice express a TCR from a diabetogenic T cell clone yet do not spontaneously develop diabetes at high incidence. Evidence exists showing that in the absence of endogenous TCR {alpha}-chain rearrangements this transgenic mouse spontaneously develops diabetes and that CTLA-4 negatively regulates diabetes onset. This strongly suggests that onset of diabetes in BDC2.5/NOD mice is governed by T cell regulation. We addressed the mechanism of immune regulation in BDC2.5/NOD mice. We find that activated spleen cells from young, but not old, BDC2.5/NOD mice are able to transfer diabetes to NOD-scid recipients. We have used anti-IL-10R to show that the failure of splenocytes from older mice to transfer diabetes is due to dominant regulation. We furthermore found that diabetes developed following anti-IL-10R treatment of 6-wk old BDC2.5/NOD mice indicating that endogenous IL-10 plays a key role in the regulation of diabetes onset in this transgenic mouse.




This article has been cited by other articles:


Home page
 DiabetesHome page
D. C. Thomas, R. J. Mellanby, and A. Cooke
Comment on: Tritt et al. (2007) Functional Waning of Naturally Occurring CD4+ Regulatory T-cells Contributes to the Onset of Autoimmune Diabetes: Diabetes 57:113-123, 2007
Diabetes, March 1, 2008; 57(3): e6 - e6.
[Full Text] [PDF]

Home page
 BloodHome page
F. J. Ward, A. M. Hall, L. S. Cairns, A. S. Leggat, S. J. Urbaniak, M. A. Vickers, and R. N. Barker
Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia
Blood, January 15, 2008; 111(2): 680 - 687.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. A. Smith, S. Efstathiou, and A. Cooke
Murine Gammaherpesvirus-68 Infection Alters Self-Antigen Presentation and Type 1 Diabetes Onset in NOD Mice
J. Immunol., December 1, 2007; 179(11): 7325 - 7333.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. A. Saunders, T. Raine, A. Cooke, and C. E. Lawrence
Inhibition of Autoimmune Type 1 Diabetes by Gastrointestinal Helminth Infection
Infect. Immun., January 1, 2007; 75(1): 397 - 407.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. Bruder, A. M. Westendorf, W. Hansen, S. Prettin, A. D. Gruber, Y. Qian, H. von Boehmer, K. Mahnke, and J. Buer
On the Edge of Autoimmunity: T-Cell Stimulation by Steady-State Dendritic Cells Prevents Autoimmune Diabetes
Diabetes, December 1, 2005; 54(12): 3395 - 3401.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. K. Gregg, J. J. Bell, H.-H. Lee, R. Jain, S. J. Schoenleber, R. Divekar, and H. Zaghouani
IL-10 Diminishes CTLA-4 Expression on Islet-Resident T Cells and Sustains Their Activation Rather Than Tolerance
J. Immunol., January 15, 2005; 174(2): 662 - 670.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Sarween, A. Chodos, C. Raykundalia, M. Khan, A. K. Abbas, and L. S. K. Walker
CD4+CD25+ Cells Controlling a Pathogenic CD4 Response Inhibit Cytokine Differentiation, CXCR-3 Expression, and Tissue Invasion
J. Immunol., September 1, 2004; 173(5): 2942 - 2951.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
A. E. Herman, G. J. Freeman, D. Mathis, and C. Benoist
CD4+CD25+ T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion
J. Exp. Med., June 7, 2004; 199(11): 1479 - 1489.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. R. Mathers and C. F. Cuff
Role of Interleukin-4 (IL-4) and IL-10 in Serum Immunoglobulin G Antibody Responses following Mucosal or Systemic Reovirus Infection
J. Virol., April 1, 2004; 78(7): 3352 - 3360.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
S. Turley, L. Poirot, M. Hattori, C. Benoist, and D. Mathis
Physiological {beta} Cell Death Triggers Priming of Self-reactive T Cells by Dendritic Cells in a Type-1 Diabetes Model
J. Exp. Med., November 17, 2003; 198(10): 1527 - 1537.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Y. C. Zhang, A. Pileggi, A. Agarwal, R. D. Molano, M. Powers, T. Brusko, C. Wasserfall, K. Goudy, E. Zahr, R. Poggioli, et al.
Adeno-Associated Virus-Mediated IL-10 Gene Therapy Inhibits Diabetes Recurrence in Syngeneic Islet Cell Transplantation of NOD Mice
Diabetes, March 1, 2003; 52(3): 708 - 716.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. M. Hall, F. J. Ward, M. A. Vickers, L.-M. Stott, S. J. Urbaniak, and R. N. Barker
Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen
Blood, December 15, 2002; 100(13): 4529 - 4536.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.